Home > Boards > Canadian > Biotechs > Eidos Therapeutics (Eidx)

News: $EIDX INVESTIGATION REMINDER: The Schall Law Firm

Public Reply | Private Reply | Keep | Last ReadPost New MsgPrevious | Next
whytestocks Member Profile
Member Level 
Followed By 24
Posts 3,292
Boards Moderated 0
Alias Born 06/04/18
160x600 placeholder
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/7/2019 4:53:28 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/6/2019 7:02:23 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/31/2019 4:20:29 PM
Amended Statement of Beneficial Ownership (sc 13d/a) Edgar (US Regulatory) - 5/30/2019 6:07:04 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/29/2019 7:20:29 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/29/2019 7:19:10 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/29/2019 7:17:09 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/29/2019 7:16:46 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/28/2019 4:02:51 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/7/2019 4:39:24 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/7/2019 4:34:09 PM
Eidos Therapeutics Reports First Quarter 2019 Financial Results GlobeNewswire Inc. - 5/7/2019 4:30:00 PM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 4/29/2019 4:27:06 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/26/2019 4:15:49 PM
Eidos Therapeutics to Present at Two Upcoming Investor Conferences GlobeNewswire Inc. - 4/19/2019 8:00:00 AM
Annual Report (10-k) Edgar (US Regulatory) - 4/15/2019 8:38:54 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/15/2019 8:31:47 AM
Eidos Therapeutics Reports Fourth Quarter and Year-End 2018 Financial Results GlobeNewswire Inc. - 4/15/2019 8:30:00 AM
Notification That Annual Report Will Be Submitted Late (nt 10-k) Edgar (US Regulatory) - 4/1/2019 5:12:10 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/1/2019 5:09:58 PM
Eidos Therapeutics Announces Publication in the Journal of the American College of Cardiology (JACC) and Presentation at Amer... GlobeNewswire Inc. - 3/18/2019 9:30:00 AM
Eidos Therapeutics to Present at 31st Annual ROTH Conference GlobeNewswire Inc. - 3/11/2019 8:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/27/2019 7:02:11 AM
Eidos Therapeutics Initiates ATTRibute-CM, a Phase 3 Study of AG10 in ATTR-CM with Registrational 12-month Endpoint GlobeNewswire Inc. - 2/27/2019 7:00:00 AM
Eidos Therapeutics to Host Conference Call and Webcast to Discuss ATTR-CM Phase 3 Trial (ATTRibute-CM) Design GlobeNewswire Inc. - 2/25/2019 8:00:00 AM
whytestocks Member Level  Friday, 04/05/19 11:50:45 AM
Re: None
Post # of 11 
News: $EIDX INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Eidos Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Eidos Therapeutics, Inc. (“Eidos” or “the Company”) (NASDAQ: EIDX ) for violations of §§10(b) and 20(a) of the Secu...

Got this from https://marketwirenews.com/news-releases/investigation-reminder-the-schall-law-firm-announces-it-is-investigating-claims-against-eidos-therapeutics-inc-and-encourages-investors-with-losses-in-excess-of-100-000-to-contact-the-firm-7952186.html

Public Reply | Private Reply | Keep | Last ReadPost New MsgPrevious | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist